BridgeMD
New treatment option for Stroke
Official title Impaired Interlimb Coordination During Locomotion in Individuals With Chronic Stroke: Contributors and Effect on Walking Function
ClinicalTrials.gov ID: NCT07006818
What this study is testing
- What it's testing
- Individuals with chronic stroke have long-term walking problems that limit community engagement and quality of life, lead to secondary disabilities, and increase healthcare costs and burden. These walking issues often persist despite rehabilitation.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 25 to 90
You may be able to join if
- Age: 25 - 90 years of age
- Monohemispheric stroke
- Chronic phase (\> 6 months post stroke)
- Ability to walk for at least 6 minutes at a self-selected comfortable speed
You likely can't join if
- Lesions affecting the brainstem or cerebellum
- Other neurological disorders
- Current botox treatments for the lower limb
- Significant cognitive or communication impairment TMS exclusion criteria
- Previous adverse reaction to TMS
- Skull abnormalities or fractures
See the full eligibility criteria
- Age: 25 - 90 years of age
- Monohemispheric stroke
- Chronic phase (\> 6 months post stroke)
- Ability to walk for at least 6 minutes at a self-selected comfortable speed
- Lesions affecting the brainstem or cerebellum
- Other neurological disorders
- Current botox treatments for the lower limb
- Significant cognitive or communication impairment TMS exclusion criteria
- Previous adverse reaction to TMS
- Skull abnormalities or fractures
- Concussion within the prior 6 months
- Unexplained, recurring headaches
- Implanted cardiac pacemaker
- Metal implants in the head or face
- History of seizures or epilepsy
- Use of medications that could increase risk of seizure
- Current pregnancy PNS \& DCS exclusion criteria
- Skin hypersensitivity at any sites of stimulation, including the scalp, thoracolumbar spine, and peripheral limbs
- History of contact dermatitis at any of the sites of stimulation
- History of allodynia and/or hyperalgesia
- Active skin infection
- Skin lesions
- Deep vein thrombosis
- Any other skin or scalp condition that could be aggravated by stimulation
- Implanted electronic, metallic, or highly conductive devices near site of stimulation that cannot be removed without permission from a health professional
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
Compensation & support
A stipend or compensation may be offered.
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 25 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.